IU researcher publishes ‘landmark’ results for curing hepatitis C in transplant patients

A new treatment regimen for hepatitis C, the most common cause of liver cancer and transplantation, has produced results that will transform treatment protocols for transplant patients, according to research published online today in the New England Journal of Medicine. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *